Pharmacokinetic comparison of two cyclosporine a formulations, SangCya (Sang-35) and neoral, in stable adult liver transplant recipients

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 394-395

  Fisher, R A ^a   Pan, S H ^b   Rossi, S J ^c   Schroeder, T J ^c   Irish, W D ^c   Canafax, D M ^c   Lopez, R R ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST VINCENT MEDICAL CENTER   (United States)

^c GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; CYCLOSPORIN A;

ADULT; AREA UNDER THE CURVE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; LIVER TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT;

ADMINISTRATION, ORAL; ADULT; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; CYCLOSPORINE; DOUBLE-BLIND METHOD; FEMALE; HALF-LIFE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED;

EID: 0032985114     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01676-5     Document Type: Conference Paper

References (3)

1. Schroeder T.J., Cho M.J., Pollock G.M., et al. J Clin Pharm. 38:1998;807.
2. Food and Drug Administration: Federal Register 1992:17997.
3. First M.R., Alloway R.R., Schroeder T.J. Clin Transplant. 12:1998;518.